Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06538714

Interval Training and Cardio-metabolic Health in Overweight/Obese Girls

Impact of Different Interval Training Protocols on Physical, Cardio-metabolic, Lipidomic, Hematological and Psychological Parameters in Young Overweight/Obese Girls

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
45 (estimated)
Sponsor
Association Tunisienne d'Etude & de Recherche sur l'Athérosclérose · Academic / Other
Sex
Female
Age
12 Years – 15 Years
Healthy volunteers
Not accepted

Summary

The main purpose of this study is to compare the impact of 12-week moderate-intensity interval training (MIIT) versus combined MIIT with high-intensity interval training (HIIT) on physical fitness, cardio metabolic, lipidomic, hematological and psychological characteristics in young overweight/obese girls.

Conditions

Interventions

TypeNameDescription
OTHERMIIT12-week supervised exercise program consisting of moderate-intensity interval training (MIIT) MIIT: 3 series of 4-8 repetitions of 30-s of work at 70-75% of MAS and 30-s of active recovery at 50% of MAS. 3 exercise sessions per week. Additionally, participants receive no individualized nutritional counseling.
OTHERMIIT + HIIT12-week supervised exercise program consisting of moderate-intensity interval training (MIIT) (6-week) and high-intensity interval training (HIIT) (6-week). MIIT: 3 series of 4-8 repetitions of 30-s of work at 70-75% of MAS and 30-s of active recovery at 50% of MAS. HIIT: 3 series of 5 repetitions of 30-s of work at 100% of MAS and 30-s of active recovery at 50% of MAS for weeks 7-9, as well as two series of 10 repetitions of 30-s of work at 100% of MAS and 30-s of active recovery at 50% of MAS for weeks 10-12. 3 exercise sessions per week. Additionally, participants receive no individualized nutritional counseling.
OTHERControl groupHabitual physical activity No additional physical intervention Additionally, participants receive no individualized nutritional counseling.

Timeline

Start date
2024-05-20
Primary completion
2024-06-20
Completion
2024-08-19
First posted
2024-08-06
Last updated
2024-08-06

Locations

2 sites across 1 country: Tunisia

Source: ClinicalTrials.gov record NCT06538714. Inclusion in this directory is not an endorsement.